Transgene Biotek Limited. - Company Profile

Q: Who are the current directors of Transgene Biotek Limited.?

The current directors of Transgene Biotek Limited. are Kollipara Koteswara Rao, Swetha Marri, Ankita Jain, Chowdari Prasad, Santhosh Kumar, Sujana Kadiam.

It is a life sciences public limited company based in Ida Bollaram, Telangana, India, established in 1990.

1990 Ida Bollaram, Telangana, India Active

Last Updated: December 20, 2025

Access Report

About Transgene Biotek Limited.

Transgene Biotek Limited., a active public limited company, was established on 01 March 1990 in Ida Bollaram, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: L85195TG1990PLC011065. Registered under ROC Roc Hyderabad. it is listed on BSE: 526139. It has an authorized capital of ₹76.00 Cr and a paid-up capital of ₹75.77 Cr.

It upholds a compliant status. Its leadership includes Kollipara Koteswara Rao (Managing Director), Swetha Marri (Director), Santhosh Kumar (Director). Past directors included Kollipara Koteswara Rao, Soma Sekhar Marthi, Puranik Sarang Subhash. It holds ₹18.53 Cr open charges and ₹3.92 Cr settled loans. Its latest AGM occurred on 05 December 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No:69 & 70, Ida Bollaram, Sangareddy District., Ida Bollaram, Telangana, 502325.

Company Details

CIN/LLPIN
L85195TG1990PLC011065
Registration Number
011065
Incorporation Date
01 March 1990
Authorized Capital
₹76.00 Cr
Paid-Up Capital
₹75.77 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 526139)
Company Status
Active

Key Metrics

Authorised Capital ₹ 76.00 Cr as on 20-12-2025
Paid Up Capital ₹ 75.77 Cr as on 20-12-2025
Company Age 35 Year, 11 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 18.53 Cr as on 20-12-2025
Satisfied Charges ₹ 3.92 Cr as on 20-12-2025
Revenue Growth **** 81.19% (FY 2024)
Profit Growth **** 89.09% (FY 2024)
Ebitda **** 41.41% (FY 2024)
Net Worth -10.72% (FY 2024)
Total Assets -0.12% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Transgene Biotek Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Transgene Biotek Limited.?

Current Directors

Name	Designation	Appointment Date	Status
Kollipara Koteswara Rao	Managing Director	04 Mar 2020	Current
Swetha Marri	Director	03 Jun 2020	Current
Santhosh Kumar	Director	12 Nov 2019	Current
Sujana Kadiam	Director	17 Apr 2015	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	04 Mar 2020	Past
Pramod Abcsdd	Director	31 Dec 2014	Past
Pramod Abcsdd	Director	28 May 2018	Past
Pramod Abcsdd	Director	28 May 2018	Past
Pramod Abcsdd	Additional Director	30 Sep 2020	Past
Pramod Abcsdd	Director	18 Feb 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Transgene Biotek.

Transgene Biotek Limited., for the financial year ended 2024, experienced significant growth in revenue, with a 81.19% increase. The company also saw a substantial improvement in profitability, with a 89.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.72%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

81.19%

*******

Revenue from Operations

*******

326.43%

*******

Total Assets

*******

-0.12%

*******

Profit or Loss

*******

89.09%

*******

Net Worth

*******

-10.72%

*******

EBITDA

*******

41.41%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Transgene Biotek?

In 2023, Transgene Biotek had a promoter holding of 21.68% and a public holding of 78.32%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹185,298,247.00

Satisfied Charges

₹39,200,000.00

Charges Breakdown by Lending Institutions

Others : 7.50 Cr
Department Of Biotechnology : 5.07 Cr
Industrial Development Bank Of India : 4.28 Cr
Ankot Tradesec Ltd. : 0.70 Cr
The Karur Vysya Bank Ltd. : 0.59 Cr
Others : 0.39 Cr

Latest Charge Details

Date	Lender	Amount	Status
11 Apr 2025	Others	₹1.50 Cr	Open
30 Jan 2025	Others	₹6.00 Cr	Open
08 Apr 2010	Department Of Biotechnology	₹5.07 Cr	Open
30 Jul 2008	Ge Capital Services India	₹0.86 M	Open
30 May 2005	The Karur Vysya Bank Ltd.	₹5.94 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Transgene Biotek?

Unlock and access historical data on people associated with Transgene Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Transgene Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transgene Biotek's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Transgene Biotek

Recent Activity within the Organization

Charges

Progress on A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101095247 was registered on 11 Apr 2025. was documented.
11 Apr 2025
Charges

A charge with Others amounted to Rs. 6.00 Cr with Charge ID 101044763 was registered on 30 Jan 2025. was recorded as a recent event.
30 Jan 2025
Annual General Meeting

Transgene Biotek Limited. last Annual general meeting of members was held on 05 Dec 2024 as per latest MCA records. was recorded as a recent event.
05 Dec 2024
Balance Sheet

The activity Transgene Biotek Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
31 Mar 2024
Charges

A charge registered on 23 May 2007 via Charge ID 10052981 with Union Bank Of India was fully satisfied on 25 May 2021. was recorded as a recent event.
25 May 2021
Director Appointment

The activity Swetha Marri was appointed as a Director was appointed as a Director on 03 Jun 2020 & has been associated with this company since 5 years 8 months . was completed.
03 Jun 2020

Explore recent activity and updates - View Recent Activity